Headline: Boston Scientific Exceeds Q4 Earnings, Revenue Expectations - BSX

[Para 1: The Lead] Boston Scientific Corp. (BSX) surpassed Wall Street earnings and revenue forecasts in its Q4 report, posting a net income of $672 million, or 45 cents per share, adjusted for non-recurring and amortization costs. The company's revenue of $5.29 billion also exceeded analyst estimates of $5.27 billion. [Para 2-3: Supporting details & Context] Boston Scientific's full-year earnings were $2.9 billion, or $1.94 per share. For the upcoming quarter ending March, the company anticipates earnings of 78 to 80 cents per share. Full-year earnings are forecasted between $3.43 to $3.49 per share. Despite a 4% decline in stock value since the start of the year, the company's performance indicates resilience. Boston Scientific's shares are traded on the NYSE.